hsa-mir-655: Hsa-mir-655 is a microRNA that has been identified as a regulator of several target genes and is involved in various biological processes [PMC5951800, PMC6888638, PMC3371699, PMC6720387, PMC7880353]. Ingenuity Pathway Analysis revealed significant enrichment of several pathways regulated by hsa-mir-655, hsa-miR-134-3p, and hsa-miR-4746 [PMC5951800]. Among the identified miRNAs, hsa-mir-655 was found to be differentially expressed in gastric adenocarcinoma [PMC6888638]. Hsa-mir-655 has been associated with muscle-tissue development and is involved in the regulation of the BMP signaling pathway [PMC3371699]. TargetScan and miRBase database analysis identified thousands of target genes for hsa-mir-655 [PMC6720387]. Hsa-mir-655 has been found to be dysregulated in ovarian cancer, with decreased expression associated with worse overall survival [PMC7880353]. In ovarian cancer cell lines, the expression levels of hsa-mir-655 were confirmed [PMC7880353]. Functional analysis revealed that hsa-mir-655 could regulate core genes involved in epithelial-to-mesenchymal transition (EMT) modulation in ovarian cancer [PMC7880353]. Hsa-mir-655 was also found to target MYC among other genes associated with poor overall survival in various cancers [PMC6680377]. Additionally, low expression levels of hsa-mir-655 were associated with poor overall survival in pancreatic ductal adenocarcinoma patients [PMC6680377].